Tectal glioma is a midbrain tumor. The patient generally presents with symptoms related to increased intracranial pressure and requires treatment for hydrocephalus. No effective pharmacological treatments have yet been introduced. This report discusses a case of a 13-year-old male diagnosed with tectal glioma who obtained a complete response and long-term survival after the treatment with antineoplastons (ANP) in phase II trial. Prior treatment consisted of placement of a ventriculoperitoneal shunt. After 6 years of stabilization there had been an increase in tumor size with signs of malignant transformation. The patient received treatment with ANP A10 and AS2-1 infusions for 20 months, obtained a complete response, and was switched to maintenance with ANP capsules. All treatments were discontinued in December 2003. Adverse events according to CTCAE v3.0 included: hypernatremia (two events of grade 3, one event of grade 2, four events of grade 1), one case of fatigue (grade 2), and one allergic reaction (grade 1). Currently, over 20 years from his diagnosis and over 13 years from treatment start he is symptom-free and leads a normal life. This report indicates that it is possible to obtain long-term survival of a child with tectal glioma with currently available investigational treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000369907 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tectal glioma: clinical, radiological, and pathological features, and the importance of molecular analysis.
Brain Tumor Pathol
October 2024
Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Article Synopsis
- Tectal glioma (TG) is a rare, lower grade glioma primarily found in children, but this study identified cases in older patients, with a median age of 30.5 years.
- The study reviewed six TG cases treated at an institute from 2005 to 2023, highlighting diverse diagnoses including pilocytic astrocytoma and high-grade gliomas, based on histological evaluations.
- Genetic analysis revealed distinct mutations in two cases, emphasizing the importance of thorough diagnostics, including molecular evaluation, to understand the varied characteristics of TG.
Modern Radiation Treatment Planning Parameters and Outcomes in Pediatric Tectal Gliomas.
Adv Radiat Oncol
April 2024
Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
Purpose: Pediatric low-grade tectal gliomas are rare, indolent tumors of the brain stem. We reviewed outcomes of pediatric patients who received a diagnosis of low-grade tectal gliomas and report dosimetric parameters for those receiving radiation therapy (RT).
Methods And Materials: We retrospectively reviewed all pediatric patients (age <18 years) at our institution diagnosed with a low-grade glioma between 1993 and 2020 (n = 288).
Diagnosis and Treatment of Sylvian Aqueduct Syndrome.
J Craniofac Surg
February 2024
Department of Neurosurgery, Yangtze River Shipping General Hospital/Wuhan Brain Hospital, Wuhan, Hubei.
Background: Sylvian aqueduct syndrome is a rare complication after ventriculoperitoneal (V-P) shunt surgery and is not easily diagnosed.
Methods: A 26-year-old male with obstructive hydrocephalus due to tectal glioma was treated with a V-P shunt surgery in another hospital. After the surgery, the patient developed an intractable disturbance of consciousness.
Pediatric tectal glioma presented with acute hydrocephalus and ventriculomegaly. Two case reports.
Arch Argent Pediatr
October 2024
Department of Neurosurgery, University of Health Sciences, Kayseri City Hospital, Kayseri, Turkey.
Tectal gliomas represent a subset of low-grade tumors that arise in the tectal region at the roof of the brainstem. Symptoms of tectal glioma include those caused by increased intracranial pressure due to obstructive hydrocephalus. Headache, blurred vision, double vision, nausea and vomiting are common symptoms.
View Article and Find Full Text PDFTectal Plate Glioma: A Clinical and Radiologic Analysis of Progression and Management in Adults.
World Neurosurg
April 2024
Department of Neurosurgery, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom; Institute of Systems, Molecular and Integrative Biology, University of Liverpool, United Kingdom.
Article Synopsis
- * A study analyzing 39 adult patients with TPGs from 1993 to 2021 found that about 20% experienced tumor progression over a median follow-up of 10 years, with a high overall survival rate of 86.5%.
- * The study highlights the importance of identifying risk factors for TPG progression and suggests that future research should focus on larger cohorts for more definitive conclusions about long-term outcomes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!